Back

Surgery in patients with infective endocarditis and prognostic importance of patient frailty

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Treatment and prevention of infective endocarditis Surgery ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Peter Laursen Graversen

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

7 More presentations in this session

Presentation thumbnail
Do we need to improve the general oral health of our population to reduce the risk of Infective Endocarditis?
Mr A. Davies De Mugica (London, GB)
Abstract Slides Video
Presentation thumbnail
Factors associated with early and late Staphylococcus aureus bacteraemia after first cardiac implantable electronic device implantation a Danish nationwide cohort study
Doctor K. Bengtsen (Roskilde, DK)
Abstract Slides Video
Presentation thumbnail
Meta-analysis of the performances of contemporary risk models in cardiac surgery for infective endocarditis
Doctor T. Wang (Cleveland, US)
Abstract Slides Video
Presentation thumbnail
A single centre retrospective analysis of the management and outcomes of cardiac device-related infective endocarditis
Doctor H. Butt (London, GB)
Abstract Slides Video
Presentation thumbnail
Blood cardioplegia may be better than crystalloid cardioplegia during cardiac surgery for infective endocarditis
Mr R. Safarov (Jena, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Treatment and prevention of infective endocarditis

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
The 5-Item Modified Frailty Index (mFI-5) for risk stratification of patients with infective endocarditis undergoing cardiac surgery
thumbnail
Congress Presentation
Clinical management and outcomes of patients with infective endocarditis according to frailty status
thumbnail
Congress Presentation
The impact of age and frailty on mortality risk among patients with first-time myocardial infarction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources